Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C

Circulation Research
S Chrissobolis, Christopher G Sobey

Abstract

The small G protein Rho and its target Rho-kinase may participate in the mechanisms underlying vascular contractile tone via inhibition of myosin light chain phosphatase. The present study has tested the hypothesis that Rho-kinase activity normally contributes to cerebral vascular tone in vivo, and that this effect is augmented during chronic hypertension. Comparative studies also examined the role of protein kinase C (PKC) in regulation of cerebral artery tone. Two Rho-kinase inhibitors, Y-27632 (0.1 to 100 micromol/L) and HA1077 (1 to 10 micromol/L), caused marked concentration-dependent increases in basilar artery diameter of anesthetized normotensive rats (Sprague-Dawley and Wistar-Kyoto [WKY] strains), as measured using a cranial window approach. By comparison, the selective PKC inhibitors calphostin C (0.01 to 0.5 micromol/L) and Ro 31-8220 (5 micromol/L) had little or no effect on basilar artery diameter. Vasodilator responses to Y-27632 were unaffected by PKC inhibition or activation. In two models of chronic hypertension (spontaneously hypertensive rats and WKY rats treated with N-nitro-L-arginine methyl ester for 4 weeks), Y-27632 elicited cerebral vasodilator responses that were significantly greater than in control ...Continue Reading

References

Jan 1, 1992·The Journal of Physiology·M A MurrayD D Heistad
Jan 1, 1991·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M SugawaT Asano
Feb 1, 1990·Nature·J L Goldstein, M S Brown
Sep 1, 1995·Journal of Vascular Research·G Osol
Dec 1, 1993·The American Journal of Physiology·J C FalconeG A Meininger
Oct 24, 1998·Trends in Pharmacological Sciences·C W Taylor, L M Broad
Apr 30, 1999·Physiological Reviews·M J Davis, M A Hill
May 29, 1999·Molecular Pharmacology·T M SeasholtzJ H Brown
Aug 24, 1999·Pharmacology & Therapeutics·N Ono-SaitoH Hidaka

❮ Previous
Next ❯

Citations

Dec 6, 2001·Current Hypertension Reports·C G Sobey, F M Faraci
Mar 23, 2002·European Journal of Pharmacology·Jiro KitayamaSetsuro Ibayashi
Aug 6, 2003·Medical Engineering & Physics·Jin YangClaudia Robertson
Jun 27, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Nami OkamuraKunio Ishii
May 29, 2012·Cardiovascular Research·Gilles KauffensteinDaniel Henrion
Sep 8, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Daniel W NunoKathryn G Lamping
Nov 26, 2004·American Journal of Respiratory and Critical Care Medicine·Tetsutaro NagaokaMasahiko Oka
Sep 17, 2005·American Journal of Respiratory Cell and Molecular Biology·Yoshihiko ChibaMiwa Misawa
Aug 9, 2008·American Journal of Respiratory Cell and Molecular Biology·Yoshihiko ChibaMiwa Misawa
Mar 29, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masahisa Asano, Yukiko Nomura
Jan 19, 2005·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Yoshihiko Chiba, Miwa Misawa
Jun 6, 2013·Cardiovascular Journal of Africa·Bonaventure AwedeVeronique Eder
Jan 16, 2002·Current Hypertension Reports·Jos P M Wesselman, Jo G R De Mey
Apr 19, 2011·Trends in Pharmacological Sciences·Márcio A F de Godoy, Satish Rattan
Apr 13, 2010·Neurosurgery Clinics of North America·J Dedrick Jordan, Paul Nyquist
May 14, 2008·Biochemical and Biophysical Research Communications·Jason H HagaTammy M Seasholtz
Jan 22, 2005·European Journal of Pharmacology·Matthias LöhnYuri Ivashchenko
Aug 2, 2005·Revista española de cardiología·Jorge JalilMaría Paz Ocaranza
Dec 27, 2005·Trends in Pharmacological Sciences·Klaudia BudzynChristopher G Sobey
Jul 12, 2005·Journal of the Neurological Sciences·Masato ShibuyaUNKNOWN Fasudil Ischemic Stroke Study Group
Sep 7, 2007·Neurological Research·Yasuhiro HashibaTomio Sasaki
Apr 8, 2010·Clinical Science·Alyson A MillerChristopher G Sobey
Nov 15, 2008·Expert Opinion on Therapeutic Targets·Hwa Kyoung ShinCenk Ayata
May 13, 2010·Biochimica Et Biophysica Acta·Angela Wirth
Aug 20, 2014·BioMed Research International·Quynh N DinhSophocles Chrissobolis
Oct 16, 2010·Journal of Pharmacological Sciences·Yoshihiko ChibaMiwa Misawa
Mar 6, 2007·Journal of Vascular Research·Duck-Sun AhnYoung-Ho Lee
Dec 15, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Yao Li, Joseph E Brayden
Dec 7, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Caroline ArnoldThomas Korff
Aug 8, 2006·Journal of Cardiovascular Pharmacology·Hui XieBillie Lou Short
Feb 12, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Gervaise LoirandPierre Pacaud
Mar 26, 2005·Neurourology and Urodynamics·Mahadevan RajasekaranMichael E Albo
May 5, 2005·Canadian Journal of Physiology and Pharmacology·Kevin S Thorneloe, Mark T Nelson
Jun 28, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Yagna P R Jarajapu, Harm J Knot
Apr 10, 2004·International Journal of Impotence Research·N WilkesM Rajasekaran
Feb 26, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yoshihiko ChibaMiwa Misawa
Feb 3, 2006·The Journal of Pharmacology and Experimental Therapeutics·Klaudia BudzynChristopher G Sobey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.